CA2237641A1 - Recepteurs du facteur neurotrophique derive de lignees de cellules gliales - Google Patents
Recepteurs du facteur neurotrophique derive de lignees de cellules gliales Download PDFInfo
- Publication number
- CA2237641A1 CA2237641A1 CA002237641A CA2237641A CA2237641A1 CA 2237641 A1 CA2237641 A1 CA 2237641A1 CA 002237641 A CA002237641 A CA 002237641A CA 2237641 A CA2237641 A CA 2237641A CA 2237641 A1 CA2237641 A1 CA 2237641A1
- Authority
- CA
- Canada
- Prior art keywords
- gdnf
- cells
- ret
- compounds
- receptors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Compounds Of Unknown Constitution (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
L'invention concerne des récepteurs du factor neurotrophique dérivé de lignées de cellules gliales (GDNF), leur expression cellulaire, leur isolement et leur caractérisation biochimique. Le récepteur c-RET est présenté comme un récepteur de GDNF. Des récepteurs nouveaux supplémentaires sont décrits ainsi que la préparation d'anticorps monoclonaux dirigés contre GDNF.
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US661995P | 1995-11-13 | 1995-11-13 | |
US1576796P | 1996-04-16 | 1996-04-16 | |
US2196596P | 1996-06-27 | 1996-06-27 | |
US2063896P | 1996-06-27 | 1996-06-27 | |
US2063996P | 1996-06-27 | 1996-06-27 | |
US60/020,639 | 1996-06-27 | ||
US60/006,619 | 1996-06-27 | ||
US60/020,638 | 1996-06-27 | ||
US60/015,767 | 1996-06-27 | ||
US60/021,965 | 1996-06-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2237641A1 true CA2237641A1 (fr) | 1997-05-22 |
Family
ID=27533181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002237641A Abandoned CA2237641A1 (fr) | 1995-11-13 | 1996-11-13 | Recepteurs du facteur neurotrophique derive de lignees de cellules gliales |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0879247A4 (fr) |
JP (1) | JP2000501924A (fr) |
KR (1) | KR19990067508A (fr) |
AU (1) | AU718979B2 (fr) |
CA (1) | CA2237641A1 (fr) |
NO (1) | NO982141L (fr) |
NZ (1) | NZ324511A (fr) |
WO (1) | WO1997018240A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6677135B1 (en) | 1996-05-08 | 2004-01-13 | Biogen, Inc. | Ret ligand (RetL) for stimulating neutral and renal growth |
ATE335003T1 (de) * | 1996-05-08 | 2006-08-15 | Biogen Idec Inc | Ret-ligand 3 (retl3), um neurales und renales wachstum zu stimulieren |
EP1119772A1 (fr) * | 1998-10-01 | 2001-08-01 | Alexey Vladimirovich Titievsky | Nouvelle voie de signalisation independante de ret pour gdnf |
US6905817B1 (en) | 1998-10-01 | 2005-06-14 | Licestia Ltd. | Ret-independent signaling pathway for GDNF |
FI20000403A0 (fi) * | 2000-02-22 | 2000-02-22 | Hannu Sariola | GDNF perhesukuisten yhdisteiden käyttö kivessyövän hoitoon tarkoitettujen tuotteiden valmistamiseksi |
TWI815793B (zh) | 2016-03-31 | 2023-09-21 | 美商恩格姆生物製藥公司 | 結合蛋白質及其使用方法 |
-
1996
- 1996-11-13 AU AU11588/97A patent/AU718979B2/en not_active Ceased
- 1996-11-13 CA CA002237641A patent/CA2237641A1/fr not_active Abandoned
- 1996-11-13 EP EP96942748A patent/EP0879247A4/fr not_active Withdrawn
- 1996-11-13 JP JP9519039A patent/JP2000501924A/ja not_active Ceased
- 1996-11-13 WO PCT/US1996/018197 patent/WO1997018240A1/fr not_active Application Discontinuation
- 1996-11-13 NZ NZ324511A patent/NZ324511A/en unknown
- 1996-11-13 KR KR1019980703530A patent/KR19990067508A/ko not_active Application Discontinuation
-
1998
- 1998-05-12 NO NO982141A patent/NO982141L/no unknown
Also Published As
Publication number | Publication date |
---|---|
KR19990067508A (ko) | 1999-08-25 |
NZ324511A (en) | 1999-09-29 |
WO1997018240A1 (fr) | 1997-05-22 |
NO982141D0 (no) | 1998-05-12 |
NO982141L (no) | 1998-07-13 |
AU1158897A (en) | 1997-06-05 |
EP0879247A1 (fr) | 1998-11-25 |
AU718979B2 (en) | 2000-05-04 |
JP2000501924A (ja) | 2000-02-22 |
EP0879247A4 (fr) | 2002-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lin et al. | Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase | |
Trupp et al. | Multiple GPI-anchored receptors control GDNF-dependent and independent activation of the c-Ret receptor tyrosine kinase | |
Pimenta et al. | The limbic system-associated membrane protein is an Ig superfamily member that mediates selective neuronal growth and axon targeting | |
Marchionni et al. | Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system | |
Partanen et al. | FGFR‐4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. | |
JP2020158546A (ja) | 筋ジストロフィー治療のためのユートロフィン誘導に関するactriibタンパク質およびその改変体およびその使用 | |
CA2409996A1 (fr) | Molecules d'acide nucleique et polypeptides nrg-2, et methodes diagnostiques et therapeutiques associees | |
AU2001274947A1 (en) | NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods | |
JP2003501089A (ja) | 改善された薬物動態特性を有する改変キメラポリペプチド | |
JPH10511840A (ja) | 形態形成タンパク質特異細胞表面レセプターおよびその使用 | |
Hart et al. | Platelet-derived growth factor receptor: current views of the two-subunit model | |
JP2000509271A (ja) | グリア細胞株由来神経栄養因子受容体 | |
US8420780B2 (en) | Mutated netrin 4, fragments thereof and uses thereof as drugs | |
TAGAWA et al. | Identification of a receptor-type protein tyrosine phosphatase expressed in postmitotic maturing neurons: its structure and expression in the central nervous system | |
JP2000514777A (ja) | 骨形成タンパク質(op−1)およびそのアナログの細胞表面レセプターalk−1およびそのアナログへの結合 | |
CA2237641A1 (fr) | Recepteurs du facteur neurotrophique derive de lignees de cellules gliales | |
US6696259B1 (en) | Assays using glial cell line-derived neurotrophic factor receptors | |
AU741208B2 (en) | Glial cell line-derived neurotrophic factor receptors | |
US7138251B1 (en) | Polynucleotides encoding a neurotrophic factor receptor | |
JP2003510029A (ja) | Egfh2遺伝子および遺伝子産物 | |
MXPA99010773A (en) | Glial cell line-derived neurotrophic factor receptors | |
MXPA98003767A (en) | Receivers of the neurotrophic factor derived from cell line gl | |
KR100409099B1 (ko) | 신경 손상 치료 기구 | |
MXPA04003421A (es) | Familias de proteinas ee3 y secuencias de adn correspondientes. | |
Lin | Expression cloning and characterization of the type II and type III TGF-β receptors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |